The Impact of Motivational Interviewing and MOTIVE Tool Use by Pharmacists on Vaccine Acceptance

Author:

Chen Aleda M. H.1ORCID,Anthony Alea1,Balogun Adeola1,Pereira Ruth1,Cole Justin W.1ORCID

Affiliation:

1. School of Pharmacy, Cedarville University, 251 N. Main St., Cedarville, OH 45314, USA

Abstract

Vaccines have played a significant role in reducing infectious disease burden. However, vaccine hesitancy remains a persistent challenge in public health, including for pharmacists who often interact with patients regarding vaccines. Thus, this study assesses the impact of motivational interviewing (MI) training and the MI-based vaccine hesitancy discussion tools (MOTIVE) on pharmacists’ management of vaccine hesitancy. Pharmacists in eight Midwestern pharmacy practices who completed MI and MOTIVE training and engaged with vaccine-hesitant patients participated in this study. The pharmacist participants completed post-encounter surveys identifying the vaccine discussed, the tool utilized, and the outcome of the conversation. Descriptive results from 362 encounters indicated that the primary reasons for hesitancy were safety (39%), care coordination (31.5%), and efficacy (30.4%). Post encounter, 35.4% of patients received vaccines, 26% planned to, 25.1% considered it, and 13.5% were uninterested. The findings highlight the importance of patient-centered communication, such as MI, between patients and pharmacists to identify and address reasons for vaccine hesitancy. Pharmacists, equipped with conversation tools such as the MOTIVE tools, may effectively influence vaccine acceptance. Future research should evaluate the utility of MI and the MOTIVE tools in other settings and regions.

Funder

Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp

Publisher

MDPI AG

Reference31 articles.

1. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States;Roush;J. Am. Med. Assoc.,2007

2. The eradication of smallpox—An overview of the past, present, and future;Henderson;Vaccine,2011

3. World Health Organization (2021, February 08). Module 1: Introduction to Vaccine Safety—History of Vaccine Development. Available online: https://vaccine-safety-training.org/history-of-vaccine-development.html.

4. (2024, May 23). Johns Hopkins University of Medicine: Coronavirus Resource Center. COVID-19 Dashboard. Available online: https://coronavirus.jhu.edu/map.html.

5. Centers for Disease Control (2024, May 23). Estimated Disease Burden of COVID-19, Available online: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/burden.html.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3